Mindmed is a neuro-pharmaceutical company that discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering.

We spoke with co-CEO JR Rahn about his path as an entrepreneur, the company’s approach to tackling the opioid crisis and their intellectual property strategy.